Natural Bone Builders

March 12, 2010 Written by JP       [Font too small?]

Some alt-med experts are suspicious of mainstream medical publications such as the The New England Journal of Medicine (NEJM). They generally believe that such periodicals are firmly in the camp or even in the pocket of allopathic medicine. While there may be some truth to that, it’s also accurate to say that unbiased articles do occasionally appear in these same journals that are often criticized. Read the following quote and tell me if it sounds like it belongs in a publication whose primary purpose is to support the existing medical and pharmaceutical paradigm: “The current drug-labeling practice for adverse events is based on the implicit assumption that an accurate portrait of patients’ subjective experiences can be provided by clinicians’ documentation alone. Yet a substantial body of evidence contradicts this assumption, showing that clinicians systematically downgrade the severity of patients’ symptoms, that patients’ self-reports frequently capture side effects that clinicians miss, and that clinicians’ failure to note these symptoms results in the occurrence of preventable adverse events”. That quote is taken directly from a current analysis entitled, “The Missing Voice of Patients in Drug-Safety Reporting” which is presented in the March 10th online edition of the NEJM.

A rather alarming presentation was also recently given at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). Researchers from Columbia University Medical Center provided data based on two new studies that the most commonly used “bone building drugs” (bisphosphonates) may actually lead to poorer bone integrity in the long term. The cause for concern involves a noted suppression of bone remodeling that appears to result in more brittle bones when these medications are used for four years or more. (1,2)

Most holistic and integrative physicians prefer to look at natural factors that may influence the organic growth and integrity of bone architecture. A recent review provided by the USDA Human Nutrition Research Center on Aging at Tufts University mentions a number of dietary components that are vital for supporting bone mineral density at all stages of life. Specifically, they encourage optimal intakes of B Vitamins, calcium, carotenoids (plant-based antioxidants), magnesium, potassium and Vitamins C, D, K. Ensuring adequate protein and reducing the consumption of cola beverages are also mentioned. (3)

According to some nutritionists, Vitamin K needs to play a more prominent role in the management of skeletal health. This is particularly important because this micronutrient is often deficient in populations that need it the most. An evaluation from earlier this year determined that older men and women were likely to have deficient levels of plasma MK-7, a biologically active form of Vitamin K. This is a pressing cause for concern because the two most common forms of K, phylloquinone (K1) and meanquinones (K2), are known to enhance bone formation, protect against bone resorption and support collagen cross-links that further strengthen the skeletal system. (4,5,6,7)

In December 2009, scientists from the Keio University School of Medicine in Japan examined the current state of evidence regarding Vitamin K interventions in relation to fracture risk. Seven randomized controlled studies were included in the evaluation. The researchers reported that despite “only a modest increase in bone density, high-dose Vitamin K supplementation improved indices of bone strength in the femoral neck and reduced the incidence of clinical fractures”. The most recent data available in the medical literature tends to support this observation. (8)

  • Supplementing with 180 mcg of the MK-7 form of Vitamin K2 results in statistically relevant changes in lumbar spine bone mineral density. So says a newly published, placebo-controlled study that followed 94 heart and lung transplant patients over the course of one year. Transplantation recipients are at a greater risk for osteoporosis. An important detail was also discovered in the course of this trial: the participants with the highest plasma K2 levels were more likely to have poorer Vitamin D status. This suggests that supplementation with Vitamin K may necessitate greater Vitamin D intake as well. (9)
  • A different form of Vitamin K2 (menatetrenone) was the focus of a current experiment involving rats who were undergoing glucocorticoid (GC) treatment. These powerful steroid medications are typically used to manage asthma, auto-immune and inflammatory conditions. They’re also notorious for negatively impacting bone density. The addition of K2 to an 8 week steroid treatment regime was shown to prevent “bone resorption while maintaining bone formation” in GC treated rats. (10)
  • *If* you decide to use a bisphosphonate medication, you may want to consider adding Vitamin K2 to your daily routine as well. A recent animal study presented in the Journal of Bone Mineral Metabolism concluded that “the combination treatment was more effective than ALN (alendronate – a bisphosphonate drug) alone for improving bone strength in OVX mice”. OVX stands for overariectomized and represents a model suggestive of menopause. (11)
Patient vs. Physician Reported Drug Side Effects
Source: NEJM – March 10th, 2010 (link)

I’m often asked about the relative importance of supplementing with calcium and Vitamin D. Some people believe that they don’t need to take additional amounts of these nutrients because they eat plenty of calcium-rich foods and spend at least some time in the sunshine. In most cases, it’s still a good idea to add supplemental calcium and D to your daily routine if you’d like to support stronger bones. Here’s why:

The results of The Osteoporosis Risk Factor and Prevention-Fracture Prevention Study (OSTPRE-FPS) was just released. This was a 3 year trial that involved 593 postmenopausal women. Roughly half consumed 1,000 mg of supplemental calcium and 800 IUs of Vitamin D per day. The others served as a control group and received only a placebo. Post trial bone density testing indicates that the participants who used the supplements had a greater total body bone mineral density at the completion of the 3 year period. Furthermore, the supplement users who were highly compliant (>80% supplement use) exhibited even greater gains in skeletal strength. The concluding remarks of the study state that “Daily Vitamin D and calcium supplementation have a positive effect on the skeleton in ambulatory postmenopausal women with adequate nutritional calcium intake”. (12)

Osteopenia and Osteoporosis are serious health concerns for all senior men and women and those who hope to one day achieve seniority. But what’s equally important is the prevention of fractures. A fracture late in life can not only be debilitating but can also dramatically increase the likelihood of serious complications and worse. The same dosage of 1,000 mg of calcium and 800 IUs of Vitamin D was recently shown to reduce total fracture risk by 17% in a group of 3,195 women aged 65-71 as compared to those using a placebo. Some areas of the body were protected to an even great extent – “distal forearm fractures” (<30%) and “upper extremity fractures” (<25%). (13)

Medications are inherently foreign to the body. There is no chemical receptor or dietary requirement for the synthetic creations contained in prescription drugs. Even medicines that try to emulate natural hormones are often problematic because they’re not identical to the hormones produced in the body. This is not to say that there aren’t instances when pharmaceutical care is advisable. I know I would certainly accept this form of treatment in situations where it was absolutely necessary. But drugs are unlikely to ever replace the natural building blocks that we all need to survive and thrive. This is why I believe that we should first examine diet and lifestyle before opting to use bone building or other medications that may have unexpected, long-term consequences.

Warning: People taking certain “blood thinning” medications should consult with their health care providers prior to increasing vitamin K consumption through diet or supplementation. (14)

Note: Please check out the “Comments & Updates” section of this blog – at the bottom of the page. You can find the latest research about this topic there!

Be well!


Bookmark and Share

Related Posts:

Tags: , , ,
Posted in Alternative Therapies, Bone and Joint Health, Nutritional Supplements

6 Comments & Updates to “Natural Bone Builders”

  1. Nina K. Says:

    Morning JP :-)

    ..i’m late: wish you both an funny relaxing weekend :-)

    Nina K.

  2. JP Says:

    Thanks, Nina! :)

    I hope you and your hubby had a great weekend as well!

    We’ve had a very busy weekend – at the Natural Products Expo West. More of that in the coming days!

    Be well!


  3. Nina K. Says:

    Morning JP :-)

    thank you! Sounds very interesting Im excited looking for the news this week… :-)

    Nina K.

  4. JP Says:

    Update 06/08/15:

    J Pineal Res. 2015 Jun 3.

    Melatonin improves bone mineral density (BMD) at the femoral neck in post-menopausal women with osteopenia: A randomized controlled trial.

    Melatonin is known for its regulation of circadian rhythm. Recently, studies have shown that melatonin may have a positive effect on the skeleton. By increasing age, the melatonin levels decrease, which may lead to a further imbalanced bone remodeling. We aimed to investigate whether treatment with melatonin could improve bone mass and integrity in humans. In a double-blind RCT, we randomized 81 post-menopausal osteopenic women to one-year daily treatment with melatonin 1mg (N=20), or 3mg (N=20), or placebo (N=41). At baseline and after one-year treatment, we measured BMD by DXA, quantitative computed tomography (QCT), and high resolution peripheral QCT (HR-pQCT), and determined calcitropic hormones and bone markers. Mean age of the study subjects was 63 (range 56-73) years. Compared to placebo, femoral neck BMD increased by 1.4% in response to melatonin (p<0.05) in a dose-dependent manner (p<0.01), as BMD increased by 0.5% in the 1mg/d group (p=0.55) and by 2.3% (p<0.01) in the 3mg/d group. In the melatonin group, trabecular thickness in tibia increased by 2.2% (p=0.04), and vBMD in the spine by 3.6% (p=0.04) in the 3mg/d. Treatment did not significantly affect BMD at other sites or levels of bone turnover markers, however, 24h urinary calcium was decreased in response to melatonin by 12.2% (p=0.02). In conclusion, one-year treatment with melatonin increased BMD at femoral neck in a dose-dependent manner, while high dose melatonin increased vBMD in the spine. Further studies are needed to assess the mechanisms of action and whether the positive effect of night-time melatonin will protect against fractures.

    Be well!


  5. JP Says:

    Updated 08/17/15:

    Updated 08/17/15:

    Evid Based Complement Alternat Med. 2015;2015:689138.

    Intake of Novel Red Clover Supplementation for 12 Weeks Improves Bone Status in Healthy Menopausal Women.

    Objective. To investigate the effect by which daily consumption of a novel red clover (RC) extract influences bone health, inflammatory status, and cardiovascular health in healthy menopausal women. Design. A 12-week randomized, double-blinded, placebo-controlled trial involving 60 menopausal women receiving a daily dose of 150 mL RC extract containing 37.1 mg isoflavones (33.8 mg as aglycones) or placebo. Methods. Bone parameters were changes in bone mineral density (BMD), bone mineral content (BMC), and T-score at the lumbar spine and femoral neck. Bone turnover (CTx) and inflammatory markers were measured in plasma and finally blood pressure (BP) was evaluated. Results. RC extract had positive effect on bone health, and only the women receiving the placebo experienced a decline in BMD (p < 0.01) at the lumbar spine. T-score at the lumbar spine only decreased in the placebo group (p < 0.01). CTx decreased in the RC group with -9.94 (±4.93)%, although not significant. Conclusion. Daily consumption of RC extract over a 12-week period was found to have a beneficial effect on bone health in menopausal women based on BMD and T-score at the lumbar spine and plasma CTx levels. No changes in BP or inflammation markers were found and no side effects were observed.

    Be well!


  6. JP Says:

    Updated 09/19/15:

    Am J Clin Nutr. 2015 Sep 16.

    No increase in risk of hip fracture at high serum retinol concentrations in community-dwelling older Norwegians: the Norwegian Epidemiologic Osteoporosis Studies.

    BACKGROUND: Norway has the highest hip fracture rates worldwide and a relatively high vitamin A intake. Increased fracture risk at high intakes and serum concentrations of retinol (s-retinol) have been observed in epidemiologic studies.

    OBJECTIVE: We aimed to study the association between s-retinol and hip fracture and whether high s-retinol may counteract a preventive effect of vitamin D.

    DESIGN: We conducted the largest prospective analysis of serum retinol and hip fracture to date in 21,774 men and women aged 65-79 y (mean age 72 y) who attended 4 community-based health studies during 1994-2001. Incident hip fractures occurring up to 10.7 y after baseline were retrieved from electronic hospital discharge registers. Retinol determined by high-pressure liquid chromatography with ultraviolet detection in stored serum was available in 1154 incident hip fracture cases with valid body mass index (BMI) data and in a subcohort defined as a sex-stratified random sample (n = 1418). Cox proportional hazards regression weighted according to the stratified case-cohort design was performed.

    RESULTS: There was a modest increased risk of hip fracture in the lowest compared with the middle quintile of s-retinol (HR: 1.41; 95% CI: 1.09, 1.82) adjusted for sex and study center. The association was attenuated after adjustment for BMI and serum concentrations of α-tocopherol (HR: 1.16; 95% CI: 0.88, 1.51). We found no increased risk in the upper compared with the middle quintile. No significant interaction between serum concentrations of 25-hydroxyvitamin D and s-retinol on hip fracture was observed (P = 0.68).

    CONCLUSIONS: We found no evidence of an adverse effect of high serum retinol on hip fracture or any interaction between retinol and 25-hydroxyvitamin D. If anything, there tended to be an increased risk at low retinol concentrations, which was attenuated after control for confounders. We propose that cod liver oil, a commonly used food supplement in Norway, should not be discouraged as a natural source of vitamin D for fracture prevention.

    Be well!


Leave a Comment

To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word